HROW Opaleye Management Inc. sells $462K worth of shares
Jun 21, 2025, 10:35 AM
0.00%
What does HROW do
Harrow, headquartered in Nashville, Tennessee, develops and sells innovative ophthalmic medications and operates ImprimisRx, employing 315 staff since its IPO on February 8, 2013. The company markets various prescription products, including VIGAMOX and IHEEZO.
Opaleye Management Inc. sold 15,204 shares of HROW on 9 June at $30.37 per share, worth a total of $462K. They now own 105,000 HROW shares, or a 13% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.